TGF-β-induced IOP elevations are mediated by RhoA in the early but not the late fibrotic phase of open angle glaucoma
Open Access
- 29 October 2018
- journal article
- research article
- Vol. 24, 712-726
Abstract
Purpose: Elevations in intraocular pressure (TOP) are associated with the development of glaucoma and loss of sight. High transforming growth factor-beta (TGF-beta) 1 levels in the eye's anterior chamber can lead to dysfunctional contractions through RhoA signaling in trabecular meshwork (TM) cells and IOP spikes. Sustained high TGF-beta levels leads to TM fibrosis and sustained increases in IOP. We investigated whether inhibiting RhoA, using a siRNA-mediated RhoA (siRhoA), controls IOP by altering TM expression of fibrosis and contractility-related proteins in a rodent model of glaucoma. Methods: TGF-beta was injected intracamerally twice a week into adult Sprague Dawley rats, and IOP was recorded with tonometry. Animals were euthanized on day 7 and 35 with TM expression of fibrosis and contractility-related proteins, as well as survival of retinal ganglion cells (RGCs) assessed with immunohistochemistry. siRNA against RhoA or enhanced green fluorescent protein (EGFP) was also injected intracamerally into select animals. Successful RhoA knockdown was determined with quantitative reverse transcription polymerase chain reaction (RT-PCR) and immunohistochemistry, and the effects of the knockdown on the parameters above analyzed. Results: TGF-beta caused increased TM contractile proteins and IOP spikes by day 7, sustained increases in IOP from day 15, and TM fibrosis at day 35. siRhoA abolished the transient 7 day IOP rise but not the later sustained IOP increase (due to fibrosis). At 35 days, TGF-beta-related RGC loss was not prevented with siRhoA treatment. Conclusions: We conclude that RhoA signaling mediates the early IOP rise induced by TM cellular changes associated with contractility but not the sustained IOP elevation caused by TM fibrosis. Thus, RhoA therapies offer a clinically relevant opportunity for IOP management, likely through the modulation of TM contractility, but appear to be ineffective in the amelioration of fibrosis.Keywords
This publication has 70 references indexed in Scilit:
- Role of TGFβ/Smad Signaling in Gremlin Induction of Human Trabecular Meshwork Extracellular Matrix ProteinsInvestigative Ophthalmology & Visual Science, 2011
- Ocular neuroprotection by siRNA targeting caspase-2Cell Death & Disease, 2011
- Quantifying E. coli Proteome and Transcriptome with Single-Molecule Sensitivity in Single CellsScience, 2010
- Mechanistic basis of Rho GTPase-induced extracellular matrix synthesis in trabecular meshwork cellsAmerican Journal of Physiology-Cell Physiology, 2010
- Adhesion signaling – crosstalk between integrins, Src and RhoJournal of Cell Science, 2009
- Latanoprost-Induced Changes in Rat Intraocular Pressure: Direct or Indirect?Journal of Ocular Pharmacology and Therapeutics, 2008
- H-1152 Effects on Intraocular Pressure and Trabecular Meshwork Morphology of Rat EyesJournal of Ocular Pharmacology and Therapeutics, 2008
- TGFβ-induced RhoA activation and fibronectin production in mesangial cells require caveolaeAmerican Journal of Physiology-Renal Physiology, 2008
- Stochastic mRNA Synthesis in Mammalian CellsPLOS Biology, 2006
- Induction of an interferon response by RNAi vectors in mammalian cellsNature Genetics, 2003